Form 4: Castle Biosciences CEO Derek Maetzold Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Castle Biosciences CEO Derek Maetzold sold shares of CSTL common stock on May 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On May 14, 2024, Derek J Maetzold, the President and CEO of Castle Biosciences, Inc. (CSTL), sold shares of the company's common stock.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2023.
- Maetzold sold a total of 3,137 shares directly at a weighted average price of $24.174 and 476 shares directly at a weighted average price of $24.949.
- He also indirectly sold 1,212 shares held by The Maetzold Descendants 2020 Trust, 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk, The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust FBO John Derek Maetzold, and The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold.
- Following the transactions, Maetzold directly owns 60,261 shares and indirectly owns 149,000 shares held by DJM Grantor Retained Annuity Trust No. 5.
- He also indirectly owns shares through various trusts for his spouse and children.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock sales under a pre-existing 10b5-1 plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, potentially leading to short-term stock price volatility.
Future Outlook
The Form 4 filing does not contain any forward-looking statements regarding the company's future performance.
Industry Context
Insider transactions are routinely monitored and reported, providing transparency to investors. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on any material non-public information.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders due to potential short-term price fluctuations.
Key Dates
| Date | Description |
|---|---|
| 2023-12-05 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-05-14 | Date of stock sale transactions |
| 2024-05-16 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.